PDCD1 and melanoma: We recently demonstrated that higher pre-treatment mast cell infiltration is significantly associated with poor responses to pre-surgical chemotherapy in an aggressive form of localized breast cancer [7], and recent data show that higher mast cell tumor infiltration predicts poor responses to anti-PD-1 ICB in melanoma [30].